title: Prospective, controlled, randomized non-blind comparison of intravenous/oral ciprofloxacin with intravenous ceftazidime in the treatment of skin or soft-tissue infections.
authors.affiliation: Department of Dermatology, Hopital General Dr. Manuel Gea Gonzalez, Mexico City, Mexico.
authors.forename: J
authors.initials: J
authors.lastname: Dominguez
authors.forename: F
authors.initials: F
authors.lastname: Palma
authors.forename: M E
authors.initials: ME
authors.lastname: Vega
authors.forename: J L
authors.initials: JL
authors.lastname: Magaña
authors.forename: G
authors.initials: G
authors.lastname: Ortiz
authors.forename: M
authors.initials: M
authors.lastname: Teresa-Hojyo
authors.forename: L
authors.initials: L
authors.lastname: Dominguez
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002442:Ceftazidime / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D011446:Prospective Studies; D011897:Random Allocation; D012874:Skin Diseases, Infectious / Q000188:drug therapy*
chemical_list: D002939:Ciprofloxacin; D002442:Ceftazidime